A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis

Despite the existence of the prophylactic Bacille Calmette-Guérin (BCG) vaccine, infection by Mycobacterium tuberculosis (Mtb) remains a major public health issue causing up to 1.8 million annual deaths worldwide. Increasing prevalence of Mtb strains resistant to antibiotics represents an urgent thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung-Theung-Long, Stéphane, Coupet, Charles-Antoine, Gouanvic, Marie, Schmitt, Doris, Ray, Aurélie, Hoffmann, Chantal, Schultz, Huguette, Tyagi, Sandeep, Soni, Heena, Converse, Paul J., Arias, Lilibeth, Kleinpeter, Patricia, Sansas, Benoît, Mdluli, Khisimuzi, Vilaplana, Cristina, Cardona, Pere-Joan, Nuermberger, Eric, Marchand, Jean-Baptiste, Silvestre, Nathalie, Inchauspé, Geneviève
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931632/
https://www.ncbi.nlm.nih.gov/pubmed/29718990
http://dx.doi.org/10.1371/journal.pone.0196815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931632/
https://www.ncbi.nlm.nih.gov/pubmed/29718990
http://dx.doi.org/10.1371/journal.pone.0196815

Ejemplares similares